Semi-automatic Segmentation Method for Determining 177Lu-DOTATATE Tumor Dosimetry

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

February 28, 2025

Conditions

Meningioma

Interventions

DEVICE

scintigraphy of 177Lu-DOTATATE

The medical device under study is a hybrid wide-field CZT solid-state camera, the VERITON-CT ™ camera.

Trial Locations (1)

Nuclear medicine Department CHRU de NANCY, Vandœuvre-lès-Nancy

All Listed Sponsors

lead

Central Hospital, Nancy, France

OTHER

NCT06460467 - Semi-automatic Segmentation Method for Determining 177Lu-DOTATATE Tumor Dosimetry | Biotech Hunter | Biotech Hunter